S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843568.62728.76 |
| _version_ | 1797287250217664512 |
|---|---|
| author | A. S. Kubasch A. Giagounidis G. Metzgeroth A. Jonasova R. Herbst J. M. T. Diaz B. De Renzis K. S. Götze M.-L. Huetter-Kroenke M.-P. Gourin B. Slama S. Dimicoli-Salazar P. Cony-Makhoul K. Laribi S. Park K. Jersemann D. Schipp K. H. Metzeler O. Tiebel K. Sockel S. Gloaguen A. Mies F. Chermat C. Thiede R. Sapena R. F. Schlenk P. Fenaux U. Platzbecker L. Ades |
| author_facet | A. S. Kubasch A. Giagounidis G. Metzgeroth A. Jonasova R. Herbst J. M. T. Diaz B. De Renzis K. S. Götze M.-L. Huetter-Kroenke M.-P. Gourin B. Slama S. Dimicoli-Salazar P. Cony-Makhoul K. Laribi S. Park K. Jersemann D. Schipp K. H. Metzeler O. Tiebel K. Sockel S. Gloaguen A. Mies F. Chermat C. Thiede R. Sapena R. F. Schlenk P. Fenaux U. Platzbecker L. Ades |
| author_sort | A. S. Kubasch |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:30:11Z |
| format | Article |
| id | doaj.art-a859409d2fd0456e81f95fe67fd2e741 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:30:11Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a859409d2fd0456e81f95fe67fd2e7412024-03-02T06:40:43ZengWileyHemaSphere2572-92412022-06-016707110.1097/01.HS9.0000843568.62728.76202206003-00070S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMESA. S. Kubasch0A. Giagounidis1G. Metzgeroth2A. Jonasova3R. Herbst4J. M. T. Diaz5B. De Renzis6K. S. Götze7M.-L. Huetter-Kroenke8M.-P. Gourin9B. Slama10S. Dimicoli-Salazar11P. Cony-Makhoul12K. Laribi13S. Park14K. Jersemann15D. Schipp16K. H. Metzeler17O. Tiebel18K. Sockel19S. Gloaguen20A. Mies21F. Chermat22C. Thiede23R. Sapena24R. F. Schlenk25P. Fenaux26U. Platzbecker27L. Ades281 Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig2 German MDS Study Group (D-MDS)5 Department of Hematology and Oncology, University Medical Centre, Mannheim, Germany61 st Medical Department - Hematology, General Hospital, Prague, Czechia7 Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany8 Department of Hematology and Oncology, CHU de Poitiers, Poitiers9 Service d’Hématologie Clinique Adulte, Clermont Ferrand, France2 German MDS Study Group (D-MDS)11 Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany12 CHU Limoges, Limoges13 Service d’Hématologie, Centre Hospitalier d’Avignon, Avignon14 University Hospital Bordeaux, Pessac15 Centre Hospitalier Annecy-Genevois, Pringy16 Centre Hospitalier Du Mans, Le Mans17 Department of Hematology, CHU Grenoble, Grenoble, France18 GWT-TUD GmbH, Dresden19 DS-Statistics, Rosenthal-Bielatal20 Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig21 Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University Dresden2 German MDS Study Group (D-MDS)2 German MDS Study Group (D-MDS)22 Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany23 Groupe Francophone des Myélodysplasies, Paris, France22 Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany23 Groupe Francophone des Myélodysplasies, Paris, France24 Department of Internal Medicine V, University Hospital of Heidelberg3 The European Myelodysplastic Syndromes Cooperative Group (EMSCO), Leipzig2 German MDS Study Group (D-MDS)3 The European Myelodysplastic Syndromes Cooperative Group (EMSCO), Leipzighttp://journals.lww.com/10.1097/01.HS9.0000843568.62728.76 |
| spellingShingle | A. S. Kubasch A. Giagounidis G. Metzgeroth A. Jonasova R. Herbst J. M. T. Diaz B. De Renzis K. S. Götze M.-L. Huetter-Kroenke M.-P. Gourin B. Slama S. Dimicoli-Salazar P. Cony-Makhoul K. Laribi S. Park K. Jersemann D. Schipp K. H. Metzeler O. Tiebel K. Sockel S. Gloaguen A. Mies F. Chermat C. Thiede R. Sapena R. F. Schlenk P. Fenaux U. Platzbecker L. Ades S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES HemaSphere |
| title | S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES |
| title_full | S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES |
| title_fullStr | S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES |
| title_full_unstemmed | S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES |
| title_short | S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES |
| title_sort | s169 clinical and molecular markers for predicting response to romiplostim treatment in lower risk myelodysplastic syndromes |
| url | http://journals.lww.com/10.1097/01.HS9.0000843568.62728.76 |
| work_keys_str_mv | AT askubasch s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT agiagounidis s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT gmetzgeroth s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT ajonasova s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT rherbst s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT jmtdiaz s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT bderenzis s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT ksgotze s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT mlhuetterkroenke s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT mpgourin s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT bslama s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT sdimicolisalazar s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT pconymakhoul s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT klaribi s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT spark s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT kjersemann s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT dschipp s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT khmetzeler s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT otiebel s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT ksockel s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT sgloaguen s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT amies s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT fchermat s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT cthiede s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT rsapena s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT rfschlenk s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT pfenaux s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT uplatzbecker s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes AT lades s169clinicalandmolecularmarkersforpredictingresponsetoromiplostimtreatmentinlowerriskmyelodysplasticsyndromes |